Cardiovascular expression of inflammatory signaling molecules, the kinin B1 receptor and COX2, in the rabbit: Effects of LPS, anti-inflammatory and anti-hypertensive drugs

Regulatory Peptides

Volumn 146, Issue 1-3, 2008, Pages 157-168

  Bawolak, Marie Thérèse ^a   Touzin, Karine ^b   Moreau, Marie Eve ^b   Désormeaux, Anik ^b   Adam, Albert ^b   Marceau, François ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Bradykinin; Dexamethasone; Enalapril; Etanercept; Losartan; Prostaglandins

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; ARGININE; BRADYKININ B1 RECEPTOR; CYCLOOXYGENASE 2; CYTOKINE; DEXAMETHASONE SODIUM PHOSPHATE; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL MALEATE; ETANERCEPT; HEART MUSCLE EXTRACT; LIPOPOLYSACCHARIDE; LOSARTAN; LYSINE; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CARDIOVASCULAR SYSTEM; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; EX VIVO STUDY; FIBROBLAST; GENE EXPRESSION; HEART MUSCLE CONTRACTILITY; HUMAN; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RABBIT; RECEPTOR UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIHYPERTENSIVE AGENTS; AORTA; CELLS, CULTURED; CYCLOOXYGENASE 2; DEXAMETHASONE; FIBROBLASTS; HUMANS; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDES; MALE; RABBITS; RECEPTOR, BRADYKININ B1; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; SIGNAL TRANSDUCTION;

ORYCTOLAGUS CUNICULUS;

EID: 38149028388     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2007.09.004     Document Type: Article

References (51)

1. Moreau M.E., Garbacki N., Molinaro G., Brown N.J., Marceau F., and Adam A. The kallikrein-kinin system: current and future pharmacological targets. J Pharm Sci 99 (2005) 6-38
2. Leeb-Lundberg L.M.F., Marceau F., Müller-Esterl W., Pettibone D.J., and Zuraw B.L. International Union of Pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev (2005) 7-77
3. Regoli D., Marceau F., and Lavigne J. Induction of the B1-receptor for kinins in the rabbit by a bacterial lipopolysaccharide. Eur J Pharmacol 71 (1981) 105-115
4. 9-bradykinin and metabolically protected agonists of B1 receptors for kinins. J Pharmacol Exp Ther 259 (1991) 997-1003
5. Marceau F., Larrivée J.F., Saint-Jacques E., and Bachvarov D.R. The kinin B1 receptor: an inducible G protein coupled receptor. Can J Physiol Pharm 75 (1997) 725-730
6. Marceau F., Larrivée J.F., Bouthillier J., Bachvarova M., Houle S., and Bachvarov D.R. Effect of endogenous kinins, prostanoids, and NO on kinin B1 and B2 receptor expression in the rabbit. Am J Physiol Regul Integr Comp Physiol 277 (1999) R1568-R1578
7. 9-bradykinin-induced coronary vasodilation. Br J Pharmacol 128 (1999) 275-282
8. deBlois D., and Horlick R.A. Endotoxin sensitization to kinin B1 receptor agonist in a non-human primate model: haemodynamic and pro-inflammatory effects. Br J Pharmacol 132 (2001) 327-335
9. Siebeck M., Spannagl E., Schorr M., Stumpf B., Fritz H., Whalley E.T., et al. Effect of combined B1 and B2 kinin receptor blockade in porcine endotoxin shock. Immunopharmacology 33 (1996) 81-84
10. Pesquero J.B., Araujo R.C., Heppenstall P.A., Stucky C.L., Silva Jr. J.A., Walther T., et al. Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc Natl Acad Sci U S A 97 (2000) 8140-8145
11. Cayla C., Todiras M., Iliescu R., Saul V.V., Gross V., Pilz B., Chai G., Merino V.F., Pesquero J.B., Baltatu O.C., and Bader M. Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension. FASEB J 21 (2007) 1689-1698
12. 9-bradykinin. Br J Pharmacol. 93 (1988) 969-977
13. 10-kallidin binding to the bradykinin B1 receptor by interleukin-1 in isolated smooth muscle cells: correlation with B1 agonist-induced PGI2 production. Br J Pharmacol 113 (1994) 389-394
14. Sabourin T., Morissette G., Bouthillier J., Levesque L., and Marceau F. Expression of kinin B1 receptor in fresh or cultured rabbit aortic smooth muscle: role of NF-κB. Am J Physiol Heart Circ Physiol 283 (2002) H227-H237
15. Moreau M.E., Bawolak M.T., Morissette G., Adam A., and Marceau F. Role of NF-κB and protein kinase C signaling in the expression of the kinin B1 receptor in human vascular smooth muscle cells. Mol Pharmacol 71 (2007) 949-956
16. Dinarello C.A. The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J Infect Dis 163 (1991) 1177-1184
17. Mease P.J. Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors. Ann Rheum Dis 61 (2002) 298-304
18. Sha B.E., Valdez H., Gelman R.S., Landay A.L., Agosti J., Mitsuyasu R., et al. Effect of etanercept (Enbrel) on interleukin 6, tumor necrosis factor alpha, and markers of immune activation in HIV-infected subjects receiving interleukin 2. AIDS Res Hum Retrovir 18 (2002) 661-665
19. Passos G.F., Fernandes E.S., Campos M.M., Araujo J.G., Pesquero J.L., Souza G.E., et al. Kinin B1 receptor up-regulation after lipopolysaccharide administration: role of proinflammatory cytokines and neutrophil influx. J Immunol 172 (2004) 1839-1847
20. Blais Jr. C., Marceau F., Rouleau J.L., and Adam A. The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins. Peptides 21 (2000) 1903-1940
21. Gainer J.V., Morrow J.D., Loveland A., King D.J., and Brown N.J. Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. N Engl J Med 339 (1998) 1285-1292
22. Drummond G.R., and Cocks T.M. Endothelium-dependent relaxations mediated by inducible B1 and constitutive B2 kinin receptors in the bovine isolated coronary artery. Br J Pharmacol. 116 (1995) 2473-2481
23. Marin-Castano M.E., Schanstra J.P., Neau E., Praddaude F., Pecher C., Ader J.L., et al. Induction of functional bradykinin B1-receptors in normotensive rats and mice under chronic angiotensin-converting enzyme inhibitor treatment. Circulation 105 (2002) 627-632
24. Moreau M.E., Dubreuil P., Molinaro G., Chagnon M., Müller-Esterl W., Lepage Y., et al. Expression of metallopeptidases and kinin receptors in swine oropharyngeal tissue: effect of ACE inhibition and inflammation. J Pharmacol Exp Ther 315 (2005) 1065-1074
25. Houston M.C. Nonsteroidal anti-inflammatory drugs and antihypertensives. Am J Med 90 suppl. 5A (1991) 42S-47S
26. Izhar M., Alausa T., Folker A., Hung E., and Bakris G.L. Effects of COX inhibition on blood pressure and kidney function in ACE inhibitor-treated Blacks and Hispanics. Hypertension 43 (2004) 573-577
27. Grundmann S., Hoefer I., Ulusans S., van Royen N., Schirmer S.H., Ozaki C.K., et al. Anti-tumor necrosis factor-α therapies attenuate adaptative arteriogenesis in the rabbit. Am J Physiol Heart Circ Physiol 289 (2005) H1497-H1505
28. Edling O., Bao G., Feelisch M., Unger T., and Gohlke P. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril. J Pharmacol Exp Ther 275 (1995) 854-863
29. Ge J., Huang D., Liang C., Luo Y., Jia Q., and Wang K. Upregulation of lectinlike oxidized low-density lipoprotein receptor-1 expression contributes to the vein graft atherosclerosis: modulation by losartan. Atherosclerosis 177 (2004) 263-268
30. Sanz M., Ganado P., and Tejerina T. Two angiotensin AT1 receptor antagonists, irbesartan and losartan, effects in cholesterol-fed rabbits. Eur J Pharmacol 442 (2002) 99-106
31. Molinaro G., Carmona A.K., Juliano M.A., Juliano L., Malitskaya E., Yessine M.A., Chagnon M., Lepage Y., Simmons W.H., Boileau G., and Adam A. Human recombinant membrane-bound aminopeptidase P: production of a soluble form and characterization using novel internally quenched fluorescent substrates. Biochem J 385 (2005) 389-397
32. Sabourin T., Guay K., Houle S., Bouthillier J., Bachvarov D.R., Adam A., et al. Absence of ligand-induced regulation of kinin receptor expression in the rabbit. Br J Pharmacol 133 (2001) 1154-1162
33. Fortin J.P., Rivard G.E., Adam A., and Marceau F. Studies on rabbit natural and recombinant tissue factors: intracellular retention and regulation of surface expression in cultured cells. Am J Physiol Heart Circ Physiol 288 (2005) H2192-H2202
34. Morissette G., Fortin J.P., Otis S., Bouthillier J., and Marceau F. A novel nonpeptide antagonist of the kinin B1 receptor: effects at the rabbit receptor. J Pharmacol Exp Ther 311 (2004) 1121-1130
35. Petitclerc E., Poubelle P.E., and Marceau F. Rapid protein synthesis and turnover is involved in interleukin-1-induced relaxation of the rabbit isolated mesenteric artery. Analysis of the arachidonate cascade. J Pharmacol Exp Ther 268 (1994) 1419-1425
36. Fleming I. Signaling by the angiotensin-converting enzyme. Circ Res 98 (2006) 887-896
37. Marceau F., Petitclerc E., deBlois D., Pradelles P., and Poubelle P.E. Human interleukin-1 induces a rapid relaxation of the rabbit isolated mesenteric artery. Br J Pharmacol 103 (1991) 1367-1372
38. Petitclerc E., Poubelle P.E., and Marceau F. Epidermal growth factor-induced rapid relaxation of the isolated rabbit mesenteric artery. Eur J Pharmacol 259 (1994) 91-94
39. Cheronis J.C. Introduction, Kinin'95 Denver. Immunopharmacology 32 (1996) 7-8
40. Guan Y., Chang M., Cho W., Zhang Y., Redha R., Davis L., Chang S., DuBois R.N., Hao C.M., and Breyer M. Cloning, expression, and regulation of rabbit cyclooxygenase-2 in renal medullary interstitial cells. Am J Physiol 273 (1997) F18-F26
41. Russo C., and Polosa R. TNF-α as a promising therapeutic target in chronic asthma: a lesson from rheumatoid arthritis. Clin Sci (Lond) 109 (2005) 135-142
42. Rayner S.A., King W.J., Comer R.M., Isaacs J.D., Hale G., George A.J., et al. Local bioactive tumour necrosis factor (TNF) in corneal allotransplantation. Clin Exp Immunol 122 (2000) 109-116
43. 9-bradykinin in vitro and in vivo. Br J Pharmacol 92 (1987) 257-264
44. Rhen T., and Cidlowski J.A. Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. N Engl J Med 353 (2005) 1711-1723
45. De Bosscher K., Vanden Berghe W., and Haegeman G. Cross-talk between nuclear receptors and nuclear factor κB. Oncogene 25 (2006) 6868-6886
46. Rivers E.P., McIntyre L., Morro D.C., and Rivers K.K. Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity. Can Med Assoc J 173 (2005) 1054-1065
47. Campos M.M., de Souza G.E.P., Ricci N.D., Pesquero J.L., Teixeira M.M., and Calixto J.B. The role of migrating leukocytes in IL-1β-induced up-regulation of kinin B1 receptors in rats. Br J Pharmacol 135 (2002) 1107-1114
48. Carter C.S., Onder G., Kritchevsky S.B., and Pahor M. Angiotensin-converting enzyme inhibition intervention in elderly persons: effects on body composition and physical performance. J Gerontol 60A (2005) 1437-1446
49. Fortin J.P., Bouthillier J., and Marceau F. High agonist-independent clearance of rabbit kinin B1 receptors in cultured cells. Am J Physiol Heart Circ Physiol 284 (2003) H1647-H1654
50. Enquist J., Skroder C., Whistler J.L., and Leeb-Lundberg L.M. Kinins promote B2 receptor endocytosis and delay constitutive B1 receptor endocytosis. Mol Pharmacol 71 (2007) 494-507
51. Kohlstedt K., Busse R., and Fleming I. Signaling via the angiotensin-converting enzyme enhances the expression of cyclooxygenase-2 in endothelial cells. Hypertension 45 (2005) 126-132